Mutation screening of TRPM1, GRM6, NYX and CACNA1F genes in patients with congenital stationary night blindness

International Journal of Molecular Medicine

Volumn 30, Issue 3, 2012, Pages 521-526

  Wang, Qin ^a   Gao, Yang ^a   Li, Shiqiang ^a   Guo, Xiangming ^a   Zhang, Qingjiong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

CACNA1F; Chinese; Congenital stationary night blindness; GRM6; Mutation; NYX; TRPM1

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL M1;

ADULT; ARTICLE; CACNA1F GENE; CLINICAL ARTICLE; CONGENITAL BLINDNESS; EXON; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GRM6 GENE; HETEROZYGOSITY; HUMAN; INTRON; MALE; NIGHT BLINDNESS; NUCLEOTIDE SEQUENCE; NYX GENE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CALCIUM CHANNELS, L-TYPE; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; MYOPIA; NIGHT BLINDNESS; PEDIGREE; PROTEOGLYCANS; RECEPTORS, GLUTAMATE; TRPM CATION CHANNELS;

EID: 84865196789     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1039     Document Type: Article

References (42)

1. Zeitz C: Molecular genetics and protein function involved in nocturnal vision. Expert Rev Ophthalmol 2: 467-485, 2007.
2. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y and Kanda T: Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 104: 1013-1020, 1986. (Pubitemid 16062068)
3. Rao VR, Cohen GB and Oprian DD: Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367: 639-642, 1994. (Pubitemid 24067704)
4. Dryja TP, McGee TL, Berson EL, et al: Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc Natl Acad Sci USA 102: 4884-4889, 2005. (Pubitemid 40471548)
5. al-Jandal N, Farrar GJ, Kiang AS, et al: A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Hum Mutat 13: 75-81, 1999. (Pubitemid 29014379)
6. Dryja TP, Hahn LB, Reboul T and Arnaud B: Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet 13: 358-360, 1996. (Pubitemid 26230505)
7. Gal A, Orth U, Baehr W, Schwinger E and Rosenberg T: Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness. Nat Genet 7: 551, 1994. (Pubitemid 24308348)
8. Zeitz C, van Genderen M, Neidhardt J, et al: Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. Invest Ophthalmol Vis Sci 46: 4328-4335, 2005. (Pubitemid 44264639)
9. Audo I, Kohl S, Leroy BP, et al: TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet 85: 720-729, 2009.
10. Li Z, Sergouniotis PI, Michaelides M, et al: Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet 85: 711-719, 2009.
11. van Genderen MM, Bijveld MM, Claassen YB, et al: Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet 85: 730-736, 2009.
12. Riazuddin SA, Shahzadi A, Zeitz C, et al: A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet 87: 523-531, 2010.
13. 2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet 79: 657-667, 2006.
14. Wycisk KA, Budde B, Feil S, et al: Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Invest Ophthalmol Vis Sci 47: 3523-3530, 2006. (Pubitemid 351639719)
15. Wycisk KA, Zeitz C, Feil S, et al: Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessive cone dystrophy. Am J Hum Genet 79: 973-977, 2006. (Pubitemid 44763412)
16. Yamamoto S, Sippel KC, Berson EL and Dryja TP: Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 15: 175-178, 1997. (Pubitemid 27061637)
17. Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y and Gal A: A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 10: 360-362, 1995.
18. Nakamura M, Yamamoto S, Okada M, Ito S, Tano Y and Miyake Y: Novel mutations in the arrestin gene and associated clinical features in Japanese patients with Oguchi's disease. Ophthalmology 111: 1410-1414, 2004. (Pubitemid 38844845)
19. Maw M, Kumaramanickavel G, Kar B, John S, Bridges R and Denton M: Two Indian siblings with Oguchi disease are homozygous for an arrestin mutation encoding premature termination. Hum Mutat (Suppl 1): S317-S319, 1998.
20. Zhang Q, Zulfiqar F, Riazuddin SA, et al: A variant form of Oguchi disease mapped to 13q34 associated with partial deletion of GRK1 gene. Mol Vis 11: 977-985, 2005. (Pubitemid 41684686)
21. Pusch CM, Zeitz C, Brandau O, et al: The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet 26: 324-327, 2000.
22. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al: Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 19: 264-267, 1998. (Pubitemid 28309339)
23. Strom TM, Nyakatura G, Apfelstedt-Sylla E, et al: An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 19: 260-263, 1998. (Pubitemid 28309338)
24. Zito I, Allen LE, Patel RJ, et al: Mutations in the CACNA1F and NYX genes in British CSNBX families. Hum Mutat 21: 169, 2003.
25. Boycott KM, Maybaum TA, Naylor MJ, et al: A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum Genet 108: 91-97, 2001. (Pubitemid 32215366)
26. Zeitz C, Minotti R, Feil S, et al: Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness. Mol Vis 11: 179-183, 2005. (Pubitemid 41358294)
27. Xiao X, Jia X, Guo X, Li S, Yang Z and Zhang Q: CSNB1 in Chinese families associated with novel mutations in NYX. J Hum Genet 51: 634-640, 2006. (Pubitemid 44048698)
28. Hoda JC, Zaghetto F, Koschak A and Striessnig J: Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. J Neurosci 25: 252-259, 2005. (Pubitemid 40110788)
29. Morgans CW, Brown RL and Duvoisin RM: TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells. Bioessays 32: 609-614, 2010.
30. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al: Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 26: 319-323, 2000.
31. Morgans CW, Ren G and Akileswaran L: Localization of nyctalopin in the mammalian retina. Eur J Neurosci 23: 1163-1171, 2006.
32. Bojang PJ, Pearring JN and Gregg RG: Nyctalopin Interacts with Transient Receptor Potential Channels in Yeast. ARVO 2009 Annual Meeting, Florida, Abst no. 5176, 2009.
33. Nakamura M, Sanuki R, Yasuma TR, et al: TRPM1 mutations are associated with the complete form of congenital stationary night blindness. Mol Vis 16: 425-437, 2010.
34. Wang Q, Wang P, Li S, et al: Mitochondrial DNA haplogroup distribution in Chaoshanese with and without myopia. Mol Vis 16: 303-309, 2010.
35. Brautigam A, Mullick T, Schliesky S and Weber AP: Critical assessment of assembly strategies for non-model species mRNA-Seq data and application of next-generation sequencing to the comparison of C3 and C4 species. J Exp Bot 62: 3093-3102, 2011.
36. Xu X, Li S, Xiao X, Wang P, Guo X and Zhang Q: Sequence variations of GRM6 in patients with high myopia. Mol Vis 15: 2094-2100, 2009.
37. Tsuchiya D, Kunishima N, Kamiya N, Jingami H and Morikawa K: Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc Natl Acad Sci USA 99: 2660-2665, 2002. (Pubitemid 34240517)
38. Kunishima N, Shimada Y, Tsuji Y, et al: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977, 2000.
39. Koike C, Obara T, Uriu Y, et al: TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci USA 107: 332-337, 2010.
40. Zeitz C, Forster U, Neidhardt J, et al: Night blindness-associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking. Hum Mutat 28: 771-780, 2007. (Pubitemid 47282438)
41. Rondard P, Liu J, Huang S, et al: Coupling of agonist binding to effector domain activation in metabotropic glutamate-like receptors. J Biol Chem 281: 24653-24661, 2006. (Pubitemid 44274238)
42. Peloquin JB, Rehak R, Doering CJ and McRory JE: Functional analysis of congenital stationary night blindness type-2 CACNA1F mutations F742C, G1007R, and R1049W. Neuroscience 150: 335-345, 2007. (Pubitemid 350198702)